Wall Street is positive on Humanigen Inc (HGEN). On average, analysts give Humanigen Inc a Buy rating. The average price target is $19, which means analysts expect the stock to climb by 3625.49% over the next twelve months. That average ranking earns Humanigen Inc an Analyst Rating of 30, which is better than 30% of stocks based on data compiled by InvestorsObserver.
Wall Street analysts are rating HGEN a Buy today. Find out what this means to you and get the rest of the rankings on HGEN!